Janssen Pharmaceuticals Inc. v. A.Y.
Petition for certiorari denied on May 17, 2021
Issue: Whether federal law preempts state-law claims that a manufacturer failed to provide adequate
warnings relating to the off-label use of their products,
where federal law bars the manufacturer from
unilaterally altering its labeling to provide such
warnings.
| Date | Proceedings and Orders (key to color coding) |
|---|
| Jan 29 2021 | Petition for a writ of certiorari filed. (Response due March 8, 2021) |
| Feb 11 2021 | Motion to extend the time to file a response from March 8, 2021 to April 7, 2021, submitted to The Clerk. |
| Feb 12 2021 | Motion to extend the time to file a response is granted and the time is extended to and including April 7, 2021. |
| Mar 04 2021 | Brief amicus curiae of Product Liability Advisory Council, Inc. filed. |
| Mar 05 2021 | Brief amicus curiae of Washington Legal Foundation filed. |
| Mar 08 2021 | Brief amici curiae of Pharmaceutical Research and Manufacturers of America, Chamber of Commerce of the United States of America, and American Tort Reform Association filed. |
| Mar 08 2021 | Brief amici curiae of National Association of Manufacturers and International Association of Defense Counsel filed. |
| Apr 07 2021 | Brief of respondents A.Y. and Billy Ann Yount in opposition filed. |
| Apr 21 2021 | DISTRIBUTED for Conference of 5/13/2021. |
| Apr 21 2021 | Reply of petitioners Janssen Pharmaceuticals, Inc., et al. filed. (Distributed) |
| May 17 2021 | Petition DENIED. Justice Alito took no part in the consideration or decision of this petition. |
